SCHEMBL6790530

SCHEMBL6790530

[CH2]N(C)c1cc(C)nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
NCF1 P14598 6/20 0.53
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2C19 P33261 1/20 0.42
GPR3 P46089 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6790532 0.85 CYP1A2 (0.60) CYP1A2NCF1KDM4EUSP2ALDH1A1
SCHEMBL30367038 0.77 CYP1A2 (0.50) CYP1A2NCF1KDM4EALDH1A1MAPT
SCHEMBL30367104 0.77 CYP1A2 (0.50) CYP1A2NCF1
SCHEMBL30367213 0.76 CYP1A2 (0.49) CYP1A2NCF1KDM4EALDH1A1MAPT
SCHEMBL4863068 0.76 NCF1 (0.50) CYP1A2NCF1KDM4EALDH1A1MAPT
SCHEMBL6185025 0.73 NCF1 (0.51) CYP1A2NCF1KDM4EMAPTL3MBTL1
SCHEMBL8894367 0.73 CYP1A2 (0.50) CYP1A2NCF1MAPTL3MBTL1CYP2C19
SCHEMBL898963 0.73 NCF1 (0.53) CYP1A2NCF1KDM4EMEN1HTT
SCHEMBL2641557 0.73 CYP1A2 (0.64) CYP1A2NCF1KDM4EUSP2ALDH1A1
SCHEMBL29502790 0.72 CYP1A2 (1.00) CYP1A2NCF1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825215-B2 N-HYDROXY-2-(2-(((4-((2-METHYL-4-QUINOLINYL)METHOXY)PHENYL) -SULFONYL)METHYL)-2-PYRROLIDINYL)ACETAMIDE, FOR EXAMPLE AND OTHER QUINOLINE CONTAINING N-HYDROXYACETAMIDE DERIVATIVES BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-11-30 US disclosed